Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Xiaoyan Xu, Tianhao Zhou, Xudong Wei, Xuelian Jiang & Jiyan Cao. (2023) Application of mPEG-CS-cRGD/Bmi-1RNAi-PTX nanoparticles in suppression of laryngeal cancer by targeting cancer stem cells. Drug Delivery 30:1.
Read now
Read now
Seyedeh Melika Ahmadi, Shervin Amirkhanloo, Rezvan Yazdian-Robati, Hossein Ebrahimi, Faezeh Hosseini Pirhayati, Waleed H. Almalki, Pedram Ebrahimnejad & Prashant Kesharwani. (2023) Recent advances in novel miRNA mediated approaches for targeting breast cancer. Journal of Drug Targeting 31:8, pages 777-793.
Read now
Read now
Mohamed Fawzi Kabil, Osama A. Badary, Frank Bier, Shaker A. Mousa & Ibrahim M. El-Sherbiny. (2023) A comprehensive review on lipid nanocarrier systems for cancer treatment: fabrication, future prospects and clinical trials. Journal of Liposome Research 0:0, pages 1-43.
Read now
Read now
Li Lv, Yonghui Shi, Junyan Wu & Guocheng Li. (2021) Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting. International Journal of Nanomedicine 16, pages 1487-1508.
Read now
Read now
Ying Zhang, Bin Xu & Xi-ping Zhang. (2018) Effects of miRNAs on functions of breast cancer stem cells and treatment of breast cancer. OncoTargets and Therapy 11, pages 4263-4270.
Read now
Read now
Leila Farahmand, Behrad Darvishi, Malihe Salehi, Sarvnaz Samadi Kouchaksaraei & Keivan Majidzadeh-A. (2018) Functionalised nanomaterials for eradication of CSCs, a promising approach for overcoming tumour heterogeneity. Journal of Drug Targeting 26:8, pages 649-657.
Read now
Read now
Articles from other publishers (60)
Bandana Chakravarti, Jawed Akhtar Siddiqui, Rohit Anthony Sinha & Sana Raza. (2023) Targeting autophagy and lipid metabolism in cancer stem cells. Biochemical Pharmacology 212, pages 115550.
Crossref
Crossref
Emine Bayraktar, Recep Bayraktar, Hulya Oztatlici, Gabriel Lopez-Berestein, Paola Amero & Cristian Rodriguez-Aguayo. (2023) Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update. Non-Coding RNA 9:2, pages 27.
Crossref
Crossref
Durgaramani Sivadasan, Kalaivanan Ramakrishnan, Janani Mahendran, Hariprasad Ranganathan, Arjunan Karuppaiah & Habibur Rahman. (2023) Solid Lipid Nanoparticles: Applications and Prospects in Cancer Treatment. International Journal of Molecular Sciences 24:7, pages 6199.
Crossref
Crossref
Júlia German-Cortés, Mireia Vilar-Hernández, Diana Rafael, Ibane Abasolo & Fernanda Andrade. (2023) Solid Lipid Nanoparticles: Multitasking Nano-Carriers for Cancer Treatment. Pharmaceutics 15:3, pages 831.
Crossref
Crossref
Bruno Rodrigues Arruda, Maria Gabriela Araújo Mendes, Paulo George Cavalcante de Freitas, Alice Vitoria Frota Reis, Thayane Soares Lima, Luiziana Cavalcante Costa Fernandes Crisóstomo, Karina Alexandre Barros Nogueira, Cláudia Pessoa, Raquel Petrilli & Josimar O. Eloy. (2023) Nanocarriers for delivery of taxanes: A review on physicochemical and biological aspects. Journal of Drug Delivery Science and Technology 80, pages 104070.
Crossref
Crossref
V. S. Apollonova, E. I. Sidina, E. V. Tkachenko & A. V. Malek. (2022) MicroRNA-dependent mechanisms of taxane resistance in breast cancer. Tumors of female reproductive system 18:3, pages 52-63.
Crossref
Crossref
Xiaoman Li, Qi Jia, Yinyin Zhou, Xuan Jiang, Li Song, Yuanyuan Wu, Aiyun Wang, Wenxing Chen, Shijun Wang & Yin Lu. (2022) Tanshinone IIA attenuates the stemness of breast cancer cells via targeting the miR-125b/STARD13 axis. Experimental Hematology & Oncology 11:1.
Crossref
Crossref
María Cascallar, Pablo Hurtado, Saínza Lores, Alba Pensado-López, Ana Quelle-Regaldie, Laura Sánchez, Roberto Piñeiro & María de la Fuente. (2022) Zebrafish as a platform to evaluate the potential of lipidic nanoemulsions for gene therapy in cancer. Frontiers in Pharmacology 13.
Crossref
Crossref
Yang Shen, Nan Zhao, Nan Zhao, Xinyao Hu, Xiaoqin He, Yangtao Xu, Jiayu Chen, Wenliang Chen, Xin Liu, Zhuolin Zhou, Dedong Cao & Ximing Xu. (2022) Tumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers. International Journal of Molecular Sciences 23:18, pages 10823.
Crossref
Crossref
Jianqin Yan, Xuehua Long, Yan Liang, Fashun Li, Hongli Yu, Yifei Li, Zhipeng Li, Yu Tian, Bin He & Yong Sun. (2022) Nanodrug delivery systems and cancer stem cells: From delivery carriers to treatment. Colloids and Surfaces B: Biointerfaces 217, pages 112701.
Crossref
Crossref
Mengyao Zhu, Yingzhi Gu, Ce Bian, Xianju Xie, Yuxing Bai & Ning Zhang. (2022) Applications of Nonviral Biomaterials for microRNA Transfection in Bone Tissue Engineering. Frontiers in Materials 9.
Crossref
Crossref
Ioana Toma, Alina Silvia Porfire, Lucia Ruxandra Tefas, Ioana Berindan-Neagoe & Ioan Tomuță. (2022) A Quality by Design Approach in Pharmaceutical Development of Non-Viral Vectors with a Focus on miRNA. Pharmaceutics 14:7, pages 1482.
Crossref
Crossref
Jyothsna Manikkath, Padacherri Vethil Jishnu, Peter R Wich, Aparna Manikkath & Raghu Radhakrishnan. (2022) Nanoparticulate strategies for the delivery of miRNA mimics and inhibitors in anticancer therapy and its potential utility in oral submucous fibrosis. Nanomedicine 17:3, pages 181-195.
Crossref
Crossref
Adil A. Sayyed, Piyush Gondaliya, Palak Bhat, Mukund Mali, Neha Arya, Amit Khairnar & Kiran Kalia. (2022) Role of miRNAs in Cancer Diagnostics and Therapy: A Recent Update. Current Pharmaceutical Design 28:6, pages 471-487.
Crossref
Crossref
Mehran Alavi & Ali Nokhodchi. (2022) Micro- and nanoformulations of paclitaxel based on micelles, liposomes, cubosomes, and lipid nanoparticles: Recent advances and challenges. Drug Discovery Today 27:2, pages 576-584.
Crossref
Crossref
Lijuan Wen, Yu Peng, Kai Wang, Zhihua Huang, Shiying He, Ruiwen Xiong, Longping Wu, Fengtian Zhang & Fuqiang Hu. (2021) Regulation of pathological BBB restoration via nanostructured ROS-responsive glycolipid-like copolymer entrapping siVEGF for glioblastoma targeted therapeutics. Nano Research 15:2, pages 1455-1465.
Crossref
Crossref
Valamla Bhavana, Padakanti Sandeep Chary, Naveen Rajana & Neelesh Kumar Mehra. 2022. Targeted Nanomedicine for Breast Cancer Therapy. Targeted Nanomedicine for Breast Cancer Therapy
281
301
.
Erez Uzuner, Gizem Tugçe Ulu, Sevim Beyza Gürler & Yusuf Baran. 2022. miRNomics. miRNomics
375
422
.
Arun Kanakkanthara & John H. Miller. (2021) βIII-tubulin overexpression in cancer: Causes, consequences, and potential therapies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:2, pages 188607.
Crossref
Crossref
Mohammad Yahya Momin, Ravinder Reddy Gaddam, Madeline Kravitz, Anisha Gupta & Ajit Vikram. (2021) The Challenges and Opportunities in the Development of MicroRNA Therapeutics: A Multidisciplinary Viewpoint. Cells 10:11, pages 3097.
Crossref
Crossref
Angeliki Andrikopoulou, Almog Shalit, Eleni Zografos, Konstantinos Koutsoukos, Anna-Maria Korakiti, Michalis Liontos, Meletios-Athanasios Dimopoulos & Flora Zagouri. (2021) MicroRNAs as Potential Predictors of Response to CDK4/6 Inhibitor Treatment. Cancers 13:16, pages 4114.
Crossref
Crossref
Lv Jianghong, Meng Tingting, Zeng Yingping, Yu Tong, Zhao Lanxia, Liu Jingwen, Zhou Wentao, Chen Pengbo, Yuan Hong & Hu Fuqiang. (2021) Aptamer and Peptide-Modified Lipid-Based Drug Delivery Systems in Application of Combined Sequential Therapy of Hepatocellular Carcinoma. ACS Biomaterials Science & Engineering 7:6, pages 2558-2568.
Crossref
Crossref
Lamyaa Albakr, Fulwah Yahya Alqahtani, Fadilah Sfouq Aleanizy, Abdullah Alomrani, Mohammad Badran, Hussein Alhindas & Futwan Al-Mohanna. (2021) Improved delivery of miR-1296 loaded cationic nanoliposomes for effective suppression of triple negative breast cancer. Saudi Pharmaceutical Journal 29:5, pages 446-455.
Crossref
Crossref
Yachao Zhang, Wenjing Zhang, Yongqi Wang, Jiaojiao Zhu, Mei Zhou, Can Peng, Zhonggui He, Jin Sun, Zhenbao Li & Shuangying Gui. (2021) Emerging nanotaxanes for cancer therapy. Biomaterials 272, pages 120790.
Crossref
Crossref
Soudeh Ghafouri-Fard, Hamed Shoorei, Atefe Abak, Sayed Haidar Abbas Raza, Martin Pichler & Mohammad Taheri. (2021) Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment. Biomedicine & Pharmacotherapy 134, pages 111172.
Crossref
Crossref
Lorena del Pozo-Acebo, M-C López de las Hazas, Joao Tomé-Carneiro, Paula Gil-Cabrerizo, Rodrigo San-Cristobal, Rebeca Busto, Almudena García-Ruiz & Alberto Dávalos. (2021) Bovine Milk-Derived Exosomes as a Drug Delivery Vehicle for miRNA-Based Therapy. International Journal of Molecular Sciences 22:3, pages 1105.
Crossref
Crossref
Xiaobin Zeng, Chengxiao Liu, Jie Yao, Haoqiang Wan, Guoqing Wan, Yingpeng Li & Nianhong Chen. (2021) Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications. Pharmacological Research 163, pages 105320.
Crossref
Crossref
Hongxia Duan, Yanhong Liu, Zhonggao Gao & Wei Huang. (2021) Recent advances in drug delivery systems for targeting cancer stem cells. Acta Pharmaceutica Sinica B 11:1, pages 55-70.
Crossref
Crossref
Samipta Singh, Priya Singh, Nidhi Mishra, Priyanka Maurya, Neelu Singh, Raquibun Nisha & Shubhini A. Saraf. 2021. Advanced Drug Delivery Systems in the Management of Cancer. Advanced Drug Delivery Systems in the Management of Cancer
107
126
.
Lingyue Gao & Lihui Wang. 2021. Epigenetic Regulation in Overcoming Chemoresistance. Epigenetic Regulation in Overcoming Chemoresistance
103
119
.
Nupur Shrivastava, Ankit Parikh, Aiswarya Chaudhuri, Javed Ali, Sanjula Baboota & Sanjay Garg. 2021. Nanocarriers for the Delivery of Combination Drugs. Nanocarriers for the Delivery of Combination Drugs
259
305
.
Dexuan Xiao & Ronghui Zhou. 2021. Advances in Nanomaterials-based Cell Biology Research. Advances in Nanomaterials-based Cell Biology Research
111
136
.
Yanhong Ma, Fanghao Cai, Yangyang Li, Jianghua Chen, Fei Han & Weiqiang Lin. (2020) A review of the application of nanoparticles in the diagnosis and treatment of chronic kidney disease. Bioactive Materials 5:3, pages 732-743.
Crossref
Crossref
Lijuan Wen, Changlong Wen, Fengtian Zhang, Kai Wang, Hong Yuan & Fuqiang Hu. (2020) siRNA and chemotherapeutic molecules entrapped into a redox-responsive platform for targeted synergistic combination therapy of glioma. Nanomedicine: Nanotechnology, Biology and Medicine 28, pages 102218.
Crossref
Crossref
Xiao Liu, Hai Liu, Su-lan Wang & Jing-wen Liu. (2020) Hyaluronic acid derivative-modified nano-structured lipid carrier for cancer targeting and therapy透明质酸衍生物修饰脂质纳米载体的抗肿瘤作用及体内靶向研究. Journal of Zhejiang University-SCIENCE B 21:7, pages 571-580.
Crossref
Crossref
Yu Gao, Mingtan Tang, Euphemia Leung, Darren Svirskis, Andrew Shelling & Zimei Wu. (2020) Dual or multiple drug loaded nanoparticles to target breast cancer stem cells. RSC Advances 10:32, pages 19089-19105.
Crossref
Crossref
Lijuan Wen, Kai Wang, Fengtian Zhang, Yanan Tan, Xuwei Shang, Yun Zhu, Xueqing Zhou, Hong Yuan & Fuqiang Hu. (2020) AKT activation by SC79 to transiently re-open pathological blood brain barrier for improved functionalized nanoparticles therapy of glioblastoma. Biomaterials 237, pages 119793.
Crossref
Crossref
Xuan Liu, Xue-qing Zhou, Xu-wei Shang, Li Wang, Yi Li, Hong Yuan & Fu-qiang Hu. (2020) Inhibition of chemotherapy-related breast tumor EMT by application of redox-sensitive siRNA delivery system CSO-ss-SA/siRNA along with doxorubicin treatmentRAC1 蛋白靶向氧化还原敏感型 siRNA 递释系统抑制化疗诱导乳腺肿瘤转移的研究. Journal of Zhejiang University-SCIENCE B 21:3, pages 218-233.
Crossref
Crossref
Surasa Nagachinta, Belen Lopez Bouzo, Abi Judit Vazquez-Rios, Rafael Lopez & Maria de la Fuente. (2020) Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics. Pharmaceutics 12:2, pages 189.
Crossref
Crossref
Suzana Aulic, Domenico Marson, Erik Laurini, Maurizio Fermeglia & Sabrina Pricl. 2020. Nanomedicines for Breast Cancer Theranostics. Nanomedicines for Breast Cancer Theranostics
371
404
.
Carla Garcia-Mazas, Sheila Barrios-Esteban, Noemi Csaba & Marcos Garcia-Fuentes. 2020. Biomaterials for Cancer Therapeutics. Biomaterials for Cancer Therapeutics
365
398
.
Piyush Kumar Gupta, Gunasekaran Dharanivasan, Ranjita Misra, Santosh Gupta & Rama Shanker Verma. 2020. NanoBioMedicine. NanoBioMedicine
67
105
.
Marek Samec, Alena Liskova, Peter Kubatka, Sona Uramova, Pavol Zubor, Samson Mathews Samuel, Anthony Zulli, Martin Pec, Tibor Bielik, Kamil Biringer, Erik Kudela, Jozef Benacka, Mariusz Adamek, Luis Rodrigo, Rachele Ciccocioppo, Taeg Kyu Kwon, Denis Baranenko, Peter Kruzliak & Dietrich Büsselberg. (2019) The role of dietary phytochemicals in the carcinogenesis via the modulation of miRNA expression. Journal of Cancer Research and Clinical Oncology 145:7, pages 1665-1679.
Crossref
Crossref
Xiaoman Li, Lufeng Zheng & Tao Xi. (2019) WITHDRAWN: Tanshinone IIA-mediated inhibition on miR-125b/STARD13 axis attenuates the stemness and enhances adriamycin sensitivity of breast cancer cells. Biochimie.
Crossref
Crossref
Laura Bayón-Cordero, Itziar Alkorta & Lide Arana. (2019) Application of Solid Lipid Nanoparticles to Improve the Efficiency of Anticancer Drugs. Nanomaterials 9:3, pages 474.
Crossref
Crossref
Yen-Chang Tsai, I-Ling Teng, Si-Tse Jiang, Yi-Che Lee, Yuan-Yow Chiou & Fong-Yu Cheng. (2019) Safe Nanocomposite-Mediated Efficient Delivery of MicroRNA Plasmids for Autosomal Dominant Polycystic Kidney Disease (ADPKD) Therapy. Advanced Healthcare Materials 8:5, pages 1801358.
Crossref
Crossref
Zhiman Bai, Jing Wei, Changmin Yu, Xisi Han, Xiaofei Qin, Chengwu Zhang, Wenzhen Liao, Lin Li & Wei Huang. (2019) Non-viral nanocarriers for intracellular delivery of microRNA therapeutics. Journal of Materials Chemistry B 7:8, pages 1209-1225.
Crossref
Crossref
Dan-Dan Zhang, Yue Li, Yuan Xu, Jaejik Kim & Shuang Huang. (2018) Phosphodiesterase 7B/microRNA-200c relationship regulates triple-negative breast cancer cell growth. Oncogene 38:7, pages 1106-1120.
Crossref
Crossref
Rabiatul Basria S. M. N. Mydin, Wan Nordiana Rahman, Rosmazihana Mat Lazim, Amirah Mohd Gazzali, Nur Hazirah Mohd Azlan & Said Moshawih. 2019. Nanotechnology: Applications in Energy, Drug and Food. Nanotechnology: Applications in Energy, Drug and Food
187
207
.
Mei Yi, Junjun Li, Shengnan Chen, Jing Cai, Yuanyuan Ban, Qian Peng, Ying Zhou, Zhaoyang Zeng, Shuping Peng, Xiaoling Li, Wei Xiong, Guiyuan Li & Bo Xiang. (2018) Emerging role of lipid metabolism alterations in Cancer stem cells. Journal of Experimental & Clinical Cancer Research 37:1.
Crossref
Crossref
Jürgen Dittmer. (2018) Breast cancer stem cells: Features, key drivers and treatment options. Seminars in Cancer Biology 53, pages 59-74.
Crossref
Crossref
Shao-Qing Chen, Cheng Wang, Shan Tao, Yun-Xin Wang, Fu-Qiang Hu & Hong Yuan. (2018) Rational Design of Redox-Responsive and P-gp-Inhibitory Lipid Nanoparticles with High Entrapment of Paclitaxel for Tumor Therapy. Advanced Healthcare Materials 7:17, pages 1800485.
Crossref
Crossref
Fabio Corrà, Chiara Agnoletto, Linda Minotti, Federica Baldassari & Stefano Volinia. (2018) The Network of Non-coding RNAs in Cancer Drug Resistance. Frontiers in Oncology 8.
Crossref
Crossref
Federica Baldassari, Carlotta Zerbinati, Marco Galasso, Fabio Corrà, Linda Minotti, Chiara Agnoletto, Maurizio Previati, Carlo M. Croce & Stefano Volinia. (2018) Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors. Frontiers in Genetics 9.
Crossref
Crossref
Chen-Yang Zhao, Rui Cheng, Zhe Yang & Zhong-Min Tian. (2018) Nanotechnology for Cancer Therapy Based on Chemotherapy. Molecules 23:4, pages 826.
Crossref
Crossref
Lawei Yang, Ziying Lin, Yahong Wang, Shenglan Gao, Qinglan Li, Chunyan Li, Wenya Xu, Jie Chen, Tie Liu, Zeqing Song & Gang Liu. (2018) MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6. Molecular Carcinogenesis 57:3, pages 419-428.
Crossref
Crossref
Virginia Campani, Simona Giarra & Giuseppe De Rosa. (2018) Lipid-based core-shell nanoparticles: Evolution and potentialities in drug delivery. OpenNano 3, pages 5-17.
Crossref
Crossref
Biki Gupta, Chul Soon Yong & Jong Oh Kim. (2017) Solid matrix-based lipid nanoplatforms as carriers for combinational therapeutics in cancer. Journal of Pharmaceutical Investigation 47:6, pages 461-473.
Crossref
Crossref
Irene Faravelli & Stefania Corti. (2017) MicroRNA-Directed Neuronal Reprogramming as a Therapeutic Strategy for Neurological Diseases. Molecular Neurobiology.
Crossref
Crossref
Jörgen Elgqvist. (2017) Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications—Focus on Prostate and Breast Cancer. International Journal of Molecular Sciences 18:5, pages 1102.
Crossref
Crossref